UTILITY OF 2-DAY CARDIOPULMONARY EXERCISE TESTING PROTOCOL IN LONG-HAUL COVID (LHC) PATIENTS: PRELIMINARY DATA
Purpose: Long Haul COVID (LHC) patients have prominent symptoms of fatigue and exercise limitation. Comparisons have been made between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) and LHC, especially with respect to post-exertional malaise (PEM). Cardiopulmonary exercise testing (CPET) is a reliable and reproducible non-invasive test to assess the various organ system functions and physiologic capacity. Day to day variation in CPET performance variables, such as peak oxygen uptake (V̇O2peak) and peak work rate (WRpeak) are typically small (< 5%). However, in the CFS/ME literature, using a two-day CPET protocol (non-invasive, maximal, ramp-incremental test repeated 24hr apart) has controversially suggested that day-two V̇O2peak and WRpeak are decreased relative to day-one, in contrast to control subjects that usually increase (or maintain) these variables on day two. Some authors have attributed this difference to post-exertional malaise (PEM). This two-day CPET protocol has therefore been suggested as a possible study protocol to investigate PEM in LHC patients.
Hypothesis: We hypothesize that LHC patients will have no decrement in day-two CPET performance despite the presence of PEM on standardized questionnaire .
Methods: 22 CPETs in 11 LHC patients [mean age 53 (11)yr, n=5 female, time since COVID infection 15.2 (7.2) m, 92% outpatient illness, BMI = 34.7(7.7)kg/m2, FEV1 = 87(13)% pred, FVC = 87 (10)% pred, DLCO = 90±9% pred, TLC = 85(15)% pred, V̇O2peak = 20.14(5.0) ml/min/kg] were studied with a two day CPET protocol. The ramp-incrementation rate was 10-20W/min and selected depending on fitness level. The day-two CPET occurred 24 hr after the day-one CPET, and performed with the same incrementation rate as day-one, with lactate threshold (LT), V̇O2peak and WRpeak measured using standard techniques. PEM was subjectively assessed using the DePaul Symptom Questionnaire, Question #5 ‘Physically drained or sick after mild activity’ (5-point Likert scale) prior to CPET testing. Ratings of perceived dyspnea and leg fatigue were recorded at peak exercise using the modified 0-10 Borg’s Scale. Paired T-Tests were used for variables comparison (day one vs day two).
RESULTS: PEM ratings for the group (DePaul Questionnaire) were 2.0 (1.1), frequency and 2.5 (1.1), severity.
Conclusions: The absence of any difference in 2-day CPET performance with the presence of PEM symptoms using the DePaul Symptom Questionnaire suggests a 2-day CPET protocol may not be useful to investigate PEM in LHC patients.
CLINICAL IMPLICATIONS: The 2 day CPET protocol may not be useful as a method to investigate PEM in LHC patients.
https://journal.chestnet.org/article/S0012-3692(23)04762-1/fulltext
Purpose: Long Haul COVID (LHC) patients have prominent symptoms of fatigue and exercise limitation. Comparisons have been made between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) and LHC, especially with respect to post-exertional malaise (PEM). Cardiopulmonary exercise testing (CPET) is a reliable and reproducible non-invasive test to assess the various organ system functions and physiologic capacity. Day to day variation in CPET performance variables, such as peak oxygen uptake (V̇O2peak) and peak work rate (WRpeak) are typically small (< 5%). However, in the CFS/ME literature, using a two-day CPET protocol (non-invasive, maximal, ramp-incremental test repeated 24hr apart) has controversially suggested that day-two V̇O2peak and WRpeak are decreased relative to day-one, in contrast to control subjects that usually increase (or maintain) these variables on day two. Some authors have attributed this difference to post-exertional malaise (PEM). This two-day CPET protocol has therefore been suggested as a possible study protocol to investigate PEM in LHC patients.
Hypothesis: We hypothesize that LHC patients will have no decrement in day-two CPET performance despite the presence of PEM on standardized questionnaire .
Methods: 22 CPETs in 11 LHC patients [mean age 53 (11)yr, n=5 female, time since COVID infection 15.2 (7.2) m, 92% outpatient illness, BMI = 34.7(7.7)kg/m2, FEV1 = 87(13)% pred, FVC = 87 (10)% pred, DLCO = 90±9% pred, TLC = 85(15)% pred, V̇O2peak = 20.14(5.0) ml/min/kg] were studied with a two day CPET protocol. The ramp-incrementation rate was 10-20W/min and selected depending on fitness level. The day-two CPET occurred 24 hr after the day-one CPET, and performed with the same incrementation rate as day-one, with lactate threshold (LT), V̇O2peak and WRpeak measured using standard techniques. PEM was subjectively assessed using the DePaul Symptom Questionnaire, Question #5 ‘Physically drained or sick after mild activity’ (5-point Likert scale) prior to CPET testing. Ratings of perceived dyspnea and leg fatigue were recorded at peak exercise using the modified 0-10 Borg’s Scale. Paired T-Tests were used for variables comparison (day one vs day two).
RESULTS: PEM ratings for the group (DePaul Questionnaire) were 2.0 (1.1), frequency and 2.5 (1.1), severity.
Conclusions: The absence of any difference in 2-day CPET performance with the presence of PEM symptoms using the DePaul Symptom Questionnaire suggests a 2-day CPET protocol may not be useful to investigate PEM in LHC patients.
CLINICAL IMPLICATIONS: The 2 day CPET protocol may not be useful as a method to investigate PEM in LHC patients.
https://journal.chestnet.org/article/S0012-3692(23)04762-1/fulltext